Interpreting risk reduction in clinical trials for pulmonary arterial hypertension

Annie C. Lajoie, Sébastien Bonnet, Yves Lacasse, Jean-Christophe Lega, Steeve Provencher

Source: Eur Respir Rev, 27 (148) 180020; 10.1183/16000617.0020-2018
Journal Issue: June
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Annie C. Lajoie, Sébastien Bonnet, Yves Lacasse, Jean-Christophe Lega, Steeve Provencher. Interpreting risk reduction in clinical trials for pulmonary arterial hypertension. Eur Respir Rev, 27 (148) 180020; 10.1183/16000617.0020-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: